Catalyst Biosciences (CBIO) Technical (Analysis) Reports Catalyst Biosciences ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Catalyst Biosciences (CBIO)
Technical Analysis Report for USA stock CBIO Catalyst Biosciences. Dated: 06 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock CBIO Catalyst Biosciences then click here. or read Experts views on Catalyst Biosciences or Forecast & share price targets of Catalyst Biosciences
Catalyst Biosciences Opened at 9.52 and Closed at: 9.51, which is 1.05% of previous session's close. It moved within a range of 9.35 and 9.79
The session was a Bearish session with an average volume of 176700, which is -119.92% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
A Dead cross was found 4 days back on short term averages
Support for tomorrow is 9.21 and resistance for tomorrow is 9.65
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 9.31, 9.11 resistance for tomorrow's hourly charts is 9.75, 9.99
10 Day SMA for Catalyst Biosciences (CBIO) is 10.15 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Catalyst Biosciences (CBIO) is 11.35 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Catalyst Biosciences (CBIO) is 12.24 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 12.37 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Catalyst Biosciences is 10.54 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Catalyst Biosciences is at 11.35 and 200 DMA is at 10.54, while 50 DMA and 100 DMA are at 12.24 and 12.37 respectively
Catalyst Biosciences (CBIO) moving average of 20 SMA is at 11.35 and 20 EMA is at 10.91
| Date | Closing Price | 20 SMA | 20 EMA |
| 06 Fri Feb | 9.51 | 11.35 | 10.91 |
| 05 Thu Feb | 9.41 | 11.43 | 11.06 |
| 04 Wed Feb | 9.71 | 11.5 | 11.23 |
| 03 Tue Feb | 9.54 | 11.57 | 11.39 |
| 02 Mon Feb | 9.82 | 11.65 | 11.58 |
| 30 Fri Jan | 9.59 | 11.71 | 11.76 |
Catalyst Biosciences (CBIO) moving average of 50 SMA is at 12.24 and 50 EMA is at 11.74
| Date | Closing Price | 50 SMA | 50 EMA |
| 06 Fri Feb | 9.51 | 12.24 | 11.74 |
| 05 Thu Feb | 9.41 | 12.33 | 11.83 |
| 04 Wed Feb | 9.71 | 12.4 | 11.93 |
| 03 Tue Feb | 9.54 | 12.47 | 12.02 |
| 02 Mon Feb | 9.82 | 12.54 | 12.12 |
| 30 Fri Jan | 9.59 | 12.6 | 12.21 |
Catalyst Biosciences (CBIO) moving average of 100 SMA is at 12.37 and 100 EMA is at 11.76
| Date | Closing Price | 100 SMA | 100 EMA |
| 06 Fri Feb | 9.51 | 12.37 | 11.76 |
| 05 Thu Feb | 9.41 | 12.4 | 11.81 |
| 04 Wed Feb | 9.71 | 12.43 | 11.86 |
| 03 Tue Feb | 9.54 | 12.46 | 11.9 |
| 02 Mon Feb | 9.82 | 12.49 | 11.95 |
| 30 Fri Jan | 9.59 | 12.51 | 11.99 |
Catalyst Biosciences (CBIO) moving average of 200 SMA is at 10.54 and 200 EMA is at 10.17
| Date | Closing Price | 200 SMA | 200 EMA |
| 06 Fri Feb | 9.51 | 10.54 | 10.17 |
| 05 Thu Feb | 9.41 | 10.49 | 10.18 |
| 04 Wed Feb | 9.71 | 10.45 | 10.19 |
| 03 Tue Feb | 9.54 | 10.4 | 10.19 |
| 02 Mon Feb | 9.82 | 10.36 | 10.2 |
| 30 Fri Jan | 9.59 | 10.31 | 10.2 |
Takeda Pharmaceutical has performed better than Catalyst Biosciences in short term. You could have earned much better returns by investing in Takeda Pharmaceutical, about 21.55% more returns!
Arcus Biosciences has performed better than Catalyst Biosciences in short term. You could have earned much better returns by investing in Arcus Biosciences, about 11.96% more returns!
Baxter International has performed better than Catalyst Biosciences in short term. You could have earned much better returns by investing in Baxter International, about 14.99% more returns!
Xeris Pharmaceuticals has performed better than Catalyst Biosciences in short term. You could have earned much better returns by investing in Xeris Pharmaceuticals, about 0.26% more returns!
Catalyst Biosciences has performed better than Veracyte Inc in short term. Holding Catalyst Biosciences could be a better choice for now!
Tg Therapeutics has performed better than Catalyst Biosciences in short term. You could have earned much better returns by investing in Tg Therapeutics, about 13.26% more returns!
Catalyst Biosciences has performed better than Regenxbio Inc in short term. Holding Catalyst Biosciences could be a better choice for now!
Phibro Animal has performed better than Catalyst Biosciences in short term. You could have earned much better returns by investing in Phibro Animal, about 46.42% more returns!
Catalyst Biosciences has performed better than Luminex Corporation in short term. Holding Catalyst Biosciences could be a better choice for now!
Kezar Life has performed better than Catalyst Biosciences in short term. You could have earned much better returns by investing in Kezar Life, about 10.57% more returns!
Henry Schein has performed better than Catalyst Biosciences in short term. You could have earned much better returns by investing in Henry Schein, about 14.54% more returns!
Fonar Corporation has performed better than Catalyst Biosciences in short term. You could have earned much better returns by investing in Fonar Corporation, about 11.91% more returns!
Fennec Pharmaceuticals has performed better than Catalyst Biosciences in short term. You could have earned much better returns by investing in Fennec Pharmaceuticals, about 12.76% more returns!
Denali Therapeutics has performed better than Catalyst Biosciences in short term. You could have earned much better returns by investing in Denali Therapeutics, about 35.35% more returns!
Dermira Inc has performed better than Catalyst Biosciences in short term. You could have earned much better returns by investing in Dermira Inc, about 26.72% more returns!
Celcuity Inc has performed better than Catalyst Biosciences in short term. You could have earned much better returns by investing in Celcuity Inc, about 11.15% more returns!
Beyondspring Inc has performed better than Catalyst Biosciences in short term. You could have earned much better returns by investing in Beyondspring Inc, about 6.2% more returns!
Axogen Inc has performed better than Catalyst Biosciences in short term. You could have earned much better returns by investing in Axogen Inc, about 16.1% more returns!
Apyx Medical has performed better than Catalyst Biosciences in short term. You could have earned much better returns by investing in Apyx Medical, about 23.32% more returns!
Catalyst Biosciences Technical analysis of indicators
Price action analysis of Catalyst Biosciences (CBIO) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Catalyst Biosciences stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Catalyst Biosciences in short term and the sell signal is strong.
Catalyst Biosciences Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Catalyst Biosciences in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Catalyst Biosciences is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 10.07 and Catalyst Biosciences CBIO stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Catalyst Biosciences CBIO stock. Volume based technical analysis of Catalyst Biosciences CBIO stock is negative.
Catalyst Biosciences Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock CBIO Catalyst Biosciences These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And CBIO Experts View which covers a lot of information including buying and selling signals
CBIO future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Catalyst Biosciences or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Catalyst Biosciences (CBIO) Technical (Analysis) Reports Catalyst Biosciences ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


